[{"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-001", "question": "A 3-week-old exclusively breastfed infant presents with irritability, poor feeding, and recurrent vomiting. Physical examination reveals a lethargic infant with a bulging fontanelle and opsoclonus-myoclonus syndrome. Laboratory studies show hyponatremia (118 mEq/L), hyperkalemia (6.8 mEq/L), and hypoglycemia (38 mg/dL). Urinary corticosteroid metabolites are markedly elevated. Which genetic mutation is most likely responsible for this infant's presentation?", "options": ["CYP11B1 (11-beta-hydroxylase) mutation", "CYP21A2 (21-hydroxylase) mutation", "StAR (steroidogenic acute regulatory protein) mutation", "CYP17A1 (17-alpha-hydroxylase) mutation", "3β-hydroxysteroid dehydrogenase type 2 mutation"], "answer": "A", "answer_index": 0, "explanation": "This presentation describes the rare 'mineralocorticoid excess' variant of congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency (CYP11B1 mutation). The key distinguishing features are hypertension and hypokalemia absent despite mineralocorticoid excess symptoms, due to accumulation of deoxycorticosterone. Opsoclonus-myoclonus is an extremely rare but reported presentation. CYP21A2 deficiency typically presents with salt-wasting, not mineralocorticoid excess.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (miskeyed)\\nVerdict on keyed answer: Miskeyed – key should be B (CYP21A2), not A.\\n\\nKey stem clues: 3‑week‑old with irritability, poor feeding, recurrent vomiting, lethargy, bulging fontanelle; labs show marked hyponatremia, hyperkalemia, and hypoglycemia; urinary corticosteroid metabolites elevated. This constellation is classic for salt‑wasting congenital adrenal hyperplasia with cortisol and aldosterone deficiency. There is no evidence of mineralocorticoid excess (no hypertension, no hypokalemia, no mention of virilization or androgen excess). Opsoclonus‑myoclonus and bulging fontanelle are atypical and not specific for any adrenal enzyme defect.\\n\\nIn 11β‑hydroxylase deficiency (CYP11B1), accumulated 11‑deoxycorticosterone causes hypertension and hypokalemia, not profound salt wasting. Thus A conflicts with the core biochemical profile. 21‑hydroxylase deficiency (CYP21A2) produces glucocorticoid and mineralocorticoid deficiency with hyponatremia, hyperkalemia, hypoglycemia, and elevated steroid metabolites, making B the single best answer. Other enzyme/steroidogenic defects (C, D, E) may cause adrenal insufficiency but generally have different electrolyte or blood pressure patterns.\\n\\nMain medical accuracy issue: Explanation incorrectly characterizes the presentation as mineralocorticoid excess; labs show mineralocorticoid deficiency.\\n\\nMinimal fix: Change the keyed answer (and explanation) to CYP21A2 (21‑hydroxylase) mutation (option B).\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (miskeyed)\nVerdict on keyed answer: Miskeyed – key should be B (CYP21A2), not A.\n\nKey stem clues: 3‑week‑old with irritability, poor feeding, recurrent vomiting, lethargy, bulging fontanelle; labs show marked hyponatremia, hyperkalemia, and hypoglycemia; urinary corticosteroid metabolites elevated. This constellation is classic for salt‑wasting congenital adrenal hyperplasia with cortisol and aldosterone deficiency. There is no evidence of mineralocorticoid excess (no hypertension, no hypokalemia, no mention of virilization or androgen excess). Opsoclonus‑myoclonus and bulging fontanelle are atypical and not specific for any adrenal enzyme defect.\n\nIn 11β‑hydroxylase deficiency (CYP11B1), accumulated 11‑deoxycorticosterone causes hypertension and hypokalemia, not profound salt wasting. Thus A conflicts with the core biochemical profile. 21‑hydroxylase deficiency (CYP21A2) produces glucocorticoid and mineralocorticoid deficiency with hyponatremia, hyperkalemia, hypoglycemia, and elevated steroid metabolites, making B the single best answer. Other enzyme/steroidogenic defects (C, D, E) may cause adrenal insufficiency but generally have different electrolyte or blood pressure patterns.\n\nMain medical accuracy issue: Explanation incorrectly characterizes the presentation as mineralocorticoid excess; labs show mineralocorticoid deficiency.\n\nMinimal fix: Change the keyed answer (and explanation) to CYP21A2 (21‑hydroxylase) mutation (option B).", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-002", "question": "A 7-year-old boy with Diamond-Blackfan anemia, maintained on chronic corticosteroid therapy, develops acute respiratory distress. Chest X-ray shows diffuse ground-glass opacities. Bronchoalveolar lavage reveals lipid-laden macrophages positive with Oil Red O staining. The patient has no history of aspiration. Which specific complication of his underlying treatment is most likely responsible?", "options": ["Exogenous lipoid pneumonia from steroid inhaler propellants", "Pulmonary alveolar proteinosis secondary to immunosuppression", "Corticosteroid-induced pulmonary lipomatosis", "Systemic fat embolism from corticosteroid-induced osteonecrosis", "Pulmonary cholesterol ester deposition from dyslipidemia"], "answer": "C", "answer_index": 2, "explanation": "Corticosteroid-induced pulmonary lipomatosis is a rare complication of chronic high-dose steroid therapy characterized by lipid accumulation in pulmonary interstitial macrophages. This differs from aspiration-related lipoid pneumonia as there is no exogenous lipid source. The mechanism involves altered lipid metabolism and macrophage function. Other options represent more common entities but do not fit this specific steroid-related pathology.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 7-year-old on chronic systemic corticosteroids for Diamond-Blackfan anemia; acute respiratory distress; diffuse ground-glass opacities; BAL with lipid-laden macrophages staining with Oil Red O; no aspiration history. The question asks for a specific complication of his steroid treatment explaining endogenous lipid accumulation in the lungs.\\nOption C (corticosteroid-induced pulmonary lipomatosis) best matches: chronic systemic steroids can cause abnormal lipid metabolism and accumulation of neutral lipids in pulmonary interstitial/alveolar macrophages, producing Oil Red O–positive “lipoid pneumonia”-like findings without exogenous source.\\nWhy other options are worse: A) Exogenous lipoid pneumonia requires an inhaled/oily agent; none is given, and the stem explicitly notes no exogenous/aspiration source. B) Pulmonary alveolar proteinosis involves proteinaceous surfactant accumulation, PAS-positive material, not classic lipid-laden macrophages. D) Fat embolism presents with acute onset after trauma or orthopedic events; none is described, and it typically causes intravascular fat, not BAL macrophage lipid accumulation alone. E) Dyslipidemia from steroids can occur, but pulmonary “cholesterol ester deposition” is not a recognized specific steroid complication explaining this pattern.\\nMain medical accuracy issue: entity is rare but described; terminology is somewhat niche yet acceptable. Minimal fix: Explicitly state chronic high-dose systemic corticosteroids in the stem to tighten linkage to the intended complication.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 7-year-old on chronic systemic corticosteroids for Diamond-Blackfan anemia; acute respiratory distress; diffuse ground-glass opacities; BAL with lipid-laden macrophages staining with Oil Red O; no aspiration history. The question asks for a specific complication of his steroid treatment explaining endogenous lipid accumulation in the lungs.\nOption C (corticosteroid-induced pulmonary lipomatosis) best matches: chronic systemic steroids can cause abnormal lipid metabolism and accumulation of neutral lipids in pulmonary interstitial/alveolar macrophages, producing Oil Red O–positive “lipoid pneumonia”-like findings without exogenous source.\nWhy other options are worse: A) Exogenous lipoid pneumonia requires an inhaled/oily agent; none is given, and the stem explicitly notes no exogenous/aspiration source. B) Pulmonary alveolar proteinosis involves proteinaceous surfactant accumulation, PAS-positive material, not classic lipid-laden macrophages. D) Fat embolism presents with acute onset after trauma or orthopedic events; none is described, and it typically causes intravascular fat, not BAL macrophage lipid accumulation alone. E) Dyslipidemia from steroids can occur, but pulmonary “cholesterol ester deposition” is not a recognized specific steroid complication explaining this pattern.\nMain medical accuracy issue: entity is rare but described; terminology is somewhat niche yet acceptable. Minimal fix: Explicitly state chronic high-dose systemic corticosteroids in the stem to tighten linkage to the intended complication.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-003", "question": "A 68-year-old man presents to the ED with acute onset of 'rice-water' diarrhea profuse enough to require intravenous fluid resuscitation. He returned yesterday from a coastal business trip. Stool studies are positive for non-O1, non-O139 Vibrio cholerae. Despite aggressive volume repletion, he develops acute renal failure and profound metabolic acidosis with an anion gap of 28. Which specific toxin-mediated mechanism explains the renal failure pattern?", "options": ["Shiga-like toxin causing hemolytic uremic syndrome", "Heat-stable enterotoxin inducing prerenal azotemia", "RTX toxin causing direct tubular epithelial necrosis", "Zonula occludens toxin leading to ischemic acute tubular necrosis", "Cholera toxin-like effect with profound hypovolemia"], "answer": "C", "answer_index": 2, "explanation": "Non-O1, non-O139 V. cholerae produces RTX (repeats in toxin) toxin which has direct cytotoxic effects on renal tubular epithelium, distinguishing it from classic cholera's pure secretory diarrhea. This explains the development of intrinsic renal failure despite adequate volume repletion. Shiga toxin is produced by enterohemorrhagic E. coli, not Vibrio species. The metabolic acidosis reflects both the diarrhea losses and renal failure.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 68-year-old man; profuse “rice‑water” diarrhea; recent coastal travel; stool positive for non‑O1, non‑O139 Vibrio cholerae; develops acute renal failure and high anion gap metabolic acidosis despite aggressive volume repletion. The question asks for the *specific toxin-mediated mechanism* explaining this intrinsic renal failure pattern.\\nNon‑O1/non‑O139 V. cholerae are known to produce RTX (repeats‑in‑toxin) cytotoxins that can directly injure renal tubular epithelium, leading to intrinsic AKI that is not purely prerenal. Choice C accurately describes this mechanism.\\nOption A: Shiga-like toxin → HUS from EHEC, not Vibrio. B: Heat-stable enterotoxin is from ETEC and typically causes volume-loss prerenal azotemia, not a distinct Vibrio toxin. D: Zonula occludens toxin alters tight junctions and contributes to secretory diarrhea, not direct tubular necrosis. E: Hypovolemia/cholera toxin describes classic prerenal/intravascular depletion, which is specifically contradicted by “despite aggressive volume repletion.”\\nMain logical issue(s): None; stem sufficiently distinguishes intrinsic cytotoxic AKI from prerenal azotemia.\\nMain medical accuracy: Generally accurate, though RTX-associated renal toxicity is somewhat niche but acceptable at advanced level.\\nMinimal fix: Clarify in stem that volume status and blood pressure have normalized with treatment to underscore that prerenal azotemia is unlikely.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 68-year-old man; profuse “rice‑water” diarrhea; recent coastal travel; stool positive for non‑O1, non‑O139 Vibrio cholerae; develops acute renal failure and high anion gap metabolic acidosis despite aggressive volume repletion. The question asks for the *specific toxin-mediated mechanism* explaining this intrinsic renal failure pattern.\nNon‑O1/non‑O139 V. cholerae are known to produce RTX (repeats‑in‑toxin) cytotoxins that can directly injure renal tubular epithelium, leading to intrinsic AKI that is not purely prerenal. Choice C accurately describes this mechanism.\nOption A: Shiga-like toxin → HUS from EHEC, not Vibrio. B: Heat-stable enterotoxin is from ETEC and typically causes volume-loss prerenal azotemia, not a distinct Vibrio toxin. D: Zonula occludens toxin alters tight junctions and contributes to secretory diarrhea, not direct tubular necrosis. E: Hypovolemia/cholera toxin describes classic prerenal/intravascular depletion, which is specifically contradicted by “despite aggressive volume repletion.”\nMain logical issue(s): None; stem sufficiently distinguishes intrinsic cytotoxic AKI from prerenal azotemia.\nMain medical accuracy: Generally accurate, though RTX-associated renal toxicity is somewhat niche but acceptable at advanced level.\nMinimal fix: Clarify in stem that volume status and blood pressure have normalized with treatment to underscore that prerenal azotemia is unlikely.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-004", "question": "A 42-year-old woman presents with syncope following several days of fever, myalgias, and diarrhea. ECG shows diffuse ST-segment elevations without reciprocal changes. Echocardiogram reveals a small pericardial effusion with preserved systolic function. Troponin I is elevated at 15 ng/mL. COVID-19 PCR is negative. She recently started doxycycline for suspected Rocky Mountain spotted fever after a camping trip. Which specific pathophysiological mechanism explains this cardiovascular presentation?", "options": ["Direct bacterial invasion of myocardium causing microabscesses", "Immune complex deposition in coronary vasculature", "Rickettsial toxin-mediated coronary vasospasm", "Endothelial damage causing capillary leakage and myocardial edema", "Doxycycline-induced hypersensitivity myocarditis"], "answer": "D", "answer_index": 3, "explanation": "Rickettsial infections cause widespread endothelial damage via intracellular replication, leading to increased vascular permeability. This results in myocardial edema and dysfunction (myopericarditis) rather than discrete infarction. The ST elevations reflect epicardial involvement rather than coronary occlusion. Doxycycline hypersensitivity is possible but unlikely this early in treatment and wouldn't explain the pre-treatment symptoms. Rocky Mountain spotted fever typically causes vasculitis, not vasospasm or immune complex deposition.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Recent febrile illness with myalgias and diarrhea after camping; empiric doxycycline for suspected Rocky Mountain spotted fever; syncope; diffuse ST elevations without reciprocal changes; small pericardial effusion; elevated troponin with preserved systolic function. This constellation is most consistent with a myopericarditis pattern due to a systemic infectious/vasculitic process such as rickettsial disease, where endothelial injury and capillary leak cause myocardial edema and serosal inflammation rather than focal ischemia.\\nOption D (endothelial damage causing capillary leakage and myocardial edema) accurately reflects classic rickettsial pathophysiology—organism-induced endothelial injury with increased vascular permeability and vasculitis. Other options are less defensible: A (microabscesses) fits pyogenic bacteria, not rickettsiae; B (immune complex deposition) is not the primary mechanism in RMSF; C (toxin-mediated vasospasm) is not characteristic; E (doxycycline hypersensitivity myocarditis) is less likely given timing and the typical absence of vasculitic/pericardial pattern.\\nMain medical accuracy issues: None significant; mechanism is consistent with accepted teaching on rickettsial disease and myopericarditis.\\nMinimal fix: Explicitly state that RMSF serology or PCR later returns positive to firmly link the pathogenesis to rickettsial infection and remove any residual etiologic ambiguity.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Recent febrile illness with myalgias and diarrhea after camping; empiric doxycycline for suspected Rocky Mountain spotted fever; syncope; diffuse ST elevations without reciprocal changes; small pericardial effusion; elevated troponin with preserved systolic function. This constellation is most consistent with a myopericarditis pattern due to a systemic infectious/vasculitic process such as rickettsial disease, where endothelial injury and capillary leak cause myocardial edema and serosal inflammation rather than focal ischemia.\nOption D (endothelial damage causing capillary leakage and myocardial edema) accurately reflects classic rickettsial pathophysiology—organism-induced endothelial injury with increased vascular permeability and vasculitis. Other options are less defensible: A (microabscesses) fits pyogenic bacteria, not rickettsiae; B (immune complex deposition) is not the primary mechanism in RMSF; C (toxin-mediated vasospasm) is not characteristic; E (doxycycline hypersensitivity myocarditis) is less likely given timing and the typical absence of vasculitic/pericardial pattern.\nMain medical accuracy issues: None significant; mechanism is consistent with accepted teaching on rickettsial disease and myopericarditis.\nMinimal fix: Explicitly state that RMSF serology or PCR later returns positive to firmly link the pathogenesis to rickettsial infection and remove any residual etiologic ambiguity.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-005", "question": "A 24-year-old previously healthy man is brought to the ED after being found unconscious in his apartment. Initial Glasgow Coma Scale is 5. His friend mentions the patient was using 'poppers' recreationally. Arterial blood gas shows methemoglobin level of 25%. Despite methylene blue administration, his mental status does not improve and he requires intubation. CT head shows bilateral globus pallidus infarctions. Which specific toxic mechanism explains the neuroimaging findings?", "options": ["Nitrite-induced vasospasm of lenticulostriate arteries", "Methemoglobinemia causing hypoxic-ischemic injury", "Carbon monoxide contamination of the recreational substance", "Concomitant cyanide poisoning from impurity", "Post-anoxic necrotizing leukoencephalopathy"], "answer": "B", "answer_index": 1, "explanation": "The bilateral globus pallidus infarction pattern is characteristic of hypoxic-ischemic injury, not focal vascular occlusion. While methylene blue treats methemoglobinemia, it cannot reverse established hypoxic brain injury. Nitrite poppers cause methemoglobinemia which reduces oxygen-carrying capacity, leading to global hypoxia that selectively affects vulnerable brain regions like the globus pallidus. This differs from carbon monoxide poisoning which typically affects basal ganglia but through different mechanisms.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: M (multiple answers defensible)\\nVerdict on keyed answer: Not uniquely determinable\\nKey stem clues: young man, ‘poppers’ (alkyl nitrites), methemoglobinemia 25%, remained comatose despite methylene blue, CT with bilateral globus pallidus infarctions. Poppers (nitrites) are classically associated with methemoglobinemia; bilateral globus pallidus lesions are classic for carbon monoxide poisoning. The question asks for the specific toxic mechanism explaining this neuroimaging pattern.\\nMain logical issue(s): Globus pallidus lesions are strongly associated with CO; option C (carbon monoxide contamination) is a very plausible “specific toxic mechanism” for this imaging, especially since 25% methemoglobin is usually only moderately symptomatic, while profound coma with bilateral pallidal infarcts is typical for significant CO exposure. Option B describes a nonspecific global hypoxic-ischemic mechanism, which is less specific to the globus pallidus than CO toxicity is. Thus both B and C are defensible, and C may actually be better linked to this lesion pattern, so the keyed answer is not uniquely best.\\nMain medical accuracy issue(s): Overstates specificity of nitrite-induced methemoglobinemia for bilateral globus pallidus infarcts; underplays classic CO association.\\nMinimal fix: Explicitly state testing confirmed no carbon monoxide exposure/contamination, or remove option C and adjust the explanation accordingly.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (multiple answers defensible)\nVerdict on keyed answer: Not uniquely determinable\nKey stem clues: young man, ‘poppers’ (alkyl nitrites), methemoglobinemia 25%, remained comatose despite methylene blue, CT with bilateral globus pallidus infarctions. Poppers (nitrites) are classically associated with methemoglobinemia; bilateral globus pallidus lesions are classic for carbon monoxide poisoning. The question asks for the specific toxic mechanism explaining this neuroimaging pattern.\nMain logical issue(s): Globus pallidus lesions are strongly associated with CO; option C (carbon monoxide contamination) is a very plausible “specific toxic mechanism” for this imaging, especially since 25% methemoglobin is usually only moderately symptomatic, while profound coma with bilateral pallidal infarcts is typical for significant CO exposure. Option B describes a nonspecific global hypoxic-ischemic mechanism, which is less specific to the globus pallidus than CO toxicity is. Thus both B and C are defensible, and C may actually be better linked to this lesion pattern, so the keyed answer is not uniquely best.\nMain medical accuracy issue(s): Overstates specificity of nitrite-induced methemoglobinemia for bilateral globus pallidus infarcts; underplays classic CO association.\nMinimal fix: Explicitly state testing confirmed no carbon monoxide exposure/contamination, or remove option C and adjust the explanation accordingly.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-006", "question": "A 34-year-old G1P0 at 28 weeks gestation presents with acute abdominal pain and hypertension (160/100 mmHg). Ultrasound reveals a viable fetus with oligohydramnios and placental lakes. MRI demonstrates complete placental separation with a 'dark intraplacental band' on T2-weighted imaging. Laboratory studies show elevated AST/ALT (250/280 U/L) and low platelets (85,000/μL). Despite magnesium sulfate infusion, she develops seizures. Which specific placental pathology is confirmed by the MRI finding?", "options": ["Placental abruption with Couvelaire uterus", "Placenta accreta spectrum disorder", "Migratory placental thrombophilia", "Massive perivillous fibrin deposition", "Placental infarction from spiral artery thrombosis"], "answer": "A", "answer_index": 0, "explanation": "The 'dark intraplacental band' on T2-weighted MRI is pathognomonic for retroplacental hematoma in abruption. This case represents severe preeclampsia progressing to eclampsia with HELLP syndrome and abruption. Couvelaire uterus refers to blood infiltrating the myometrium, which can be seen with abruption. The other options describe different placental pathologies that would not typically present with this acute hypertensive picture or the specific MRI finding.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (miskeyed)\\nVerdict on keyed answer: Miskeyed — best-supported answer is E, not A.\\n\\nKey stem clues: 28 weeks, acute abdominal pain, severe hypertension, oligohydramnios, placental lakes, MRI with complete placental separation and a “dark intraplacental band” on T2, plus HELLP and eclampsia. The question asks: “Which specific placental pathology is confirmed by the MRI finding?” The T2 “dark intraplacental band” is classic for placenta accreta spectrum on MRI, not for abruption or Couvelaire uterus. Abruption is a clinical diagnosis with retroplacental hematoma; Couvelaire uterus is a uterine myometrial change, not a placental pathology. MRI finding as written (dark intraplacental band) most closely matches accreta spectrum, but option B is also not describing a separation; the stem itself is internally inconsistent with known imaging features.\\n\\nMain logical issue(s): The stem claims pathognomonic sign of abruption that is in reality described for accreta, and then asks for “specific placental pathology,” yet keys abruption/Couvelaire (a uterine finding). That makes the correct imaging association miskeyed.\\n\\nMain medical accuracy issues: Misattribution of MRI sign; confusion between retroplacental hematoma and intraplacental band.\\n\\nMinimal fix: Change the MRI phrase to “large retroplacental hematoma” and remove “dark intraplacental band”, or change the key to B and re-write the rest of the stem accordingly.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (miskeyed)\nVerdict on keyed answer: Miskeyed — best-supported answer is E, not A.\n\nKey stem clues: 28 weeks, acute abdominal pain, severe hypertension, oligohydramnios, placental lakes, MRI with complete placental separation and a “dark intraplacental band” on T2, plus HELLP and eclampsia. The question asks: “Which specific placental pathology is confirmed by the MRI finding?” The T2 “dark intraplacental band” is classic for placenta accreta spectrum on MRI, not for abruption or Couvelaire uterus. Abruption is a clinical diagnosis with retroplacental hematoma; Couvelaire uterus is a uterine myometrial change, not a placental pathology. MRI finding as written (dark intraplacental band) most closely matches accreta spectrum, but option B is also not describing a separation; the stem itself is internally inconsistent with known imaging features.\n\nMain logical issue(s): The stem claims pathognomonic sign of abruption that is in reality described for accreta, and then asks for “specific placental pathology,” yet keys abruption/Couvelaire (a uterine finding). That makes the correct imaging association miskeyed.\n\nMain medical accuracy issues: Misattribution of MRI sign; confusion between retroplacental hematoma and intraplacental band.\n\nMinimal fix: Change the MRI phrase to “large retroplacental hematoma” and remove “dark intraplacental band”, or change the key to B and re-write the rest of the stem accordingly.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-007", "question": "A 62-year-old man with esophageal cancer presents for esophagectomy. During one-lung ventilation, his oxygen saturation drops to 82%. The anesthesia team notes increased airway pressures and frothy pink secretions from the endotracheal tube. Transesophageal echocardiography shows new right ventricular dilatation with septal flattening. Despite 100% FiO2 and PEEP, hypoxia persists. Administration of which specific medication is most likely to improve oxygenation in this scenario?", "options": ["Alprostadil (prostaglandin E1)", "Inhaled epoprostenol (prostacyclin)", "Intravenous milrinone", "Inhaled nitric oxide", "Intravenous phenylephrine"], "answer": "B", "answer_index": 1, "explanation": "This scenario describes acute right ventricular failure and hypoxia during one-lung ventilation, likely due to increased pulmonary vascular resistance. Inhaled epoprostenol selectively vasodilates the ventilated lung, improving V/Q matching without systemic hypotension. Inhaled nitric oxide has similar effects but is more expensive and less readily available. Milrinone causes systemic vasodilation which could worsen hypotension. Phenylephrine would increase afterload on the failing right ventricle. Alprostadil is used for ductal patency, not acute RV failure.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: M (Multiple answers defensible)\\nVerdict on keyed answer: Not uniquely determinable\\nKey stem clues: One-lung ventilation, acute hypoxemia to 82% despite 100% FiO2 and PEEP, frothy pink secretions (acute lung injury/edema in ventilated lung), increased airway pressures, TEE with new RV dilation and septal flattening (acute pulmonary hypertension/RV failure). The clinical problem is acute RV failure with hypoxemia from increased PVR during one-lung ventilation, needing a selective pulmonary vasodilator to improve V/Q matching and unload the RV.\\nBoth inhaled epoprostenol (B) and inhaled nitric oxide (D) are standard, selective pulmonary vasodilators that reduce PVR in ventilated lung and improve oxygenation/RV function. The explanation dismisses nitric oxide on grounds of cost/availability, which is not an appropriate discriminator for a physiology/management board item; pharmacologic effect is essentially the same. Thus B and D are equivalently defensible.\\nOther options (A, C, E) are reasonably excluded.\\nMedical accuracy overall is good; the pathophysiology and drug effects are correct.\\nMinimal fix: Reword the stem to specify that inhaled nitric oxide is not available in this institution, or remove option D and replace with a clearly non–selective vasodilator so that inhaled epoprostenol is uniquely best.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible)\nVerdict on keyed answer: Not uniquely determinable\nKey stem clues: One-lung ventilation, acute hypoxemia to 82% despite 100% FiO2 and PEEP, frothy pink secretions (acute lung injury/edema in ventilated lung), increased airway pressures, TEE with new RV dilation and septal flattening (acute pulmonary hypertension/RV failure). The clinical problem is acute RV failure with hypoxemia from increased PVR during one-lung ventilation, needing a selective pulmonary vasodilator to improve V/Q matching and unload the RV.\nBoth inhaled epoprostenol (B) and inhaled nitric oxide (D) are standard, selective pulmonary vasodilators that reduce PVR in ventilated lung and improve oxygenation/RV function. The explanation dismisses nitric oxide on grounds of cost/availability, which is not an appropriate discriminator for a physiology/management board item; pharmacologic effect is essentially the same. Thus B and D are equivalently defensible.\nOther options (A, C, E) are reasonably excluded.\nMedical accuracy overall is good; the pathophysiology and drug effects are correct.\nMinimal fix: Reword the stem to specify that inhaled nitric oxide is not available in this institution, or remove option D and replace with a clearly non–selective vasodilator so that inhaled epoprostenol is uniquely best.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-008", "question": "A 45-year-old woman with metastatic carcinoid syndrome presents for emergent small bowel obstruction surgery. During anesthesia induction, she develops profound hypotension refractory to fluid boluses and phenylephrine. ECG shows sinus tachycardia with non-specific ST changes. Transesophageal echocardiography reveals global hypokinesis with apical sparing ('takotsubo-like' pattern). Which specific pharmacologic intervention is most appropriate?", "options": ["Intravenous octreotide", "Intravenous corticosteroids", "Intravenous β-blocker", "Intravenous calcium gluconate", "Intravenous methylene blue"], "answer": "A", "answer_index": 0, "explanation": "This describes carcinoid crisis mediated by massive serotonin release, causing both hypotension and catecholamine-mediated myocardial stunning (carcinoid heart disease). Octreotide is the specific antidote that inhibits serotonin release. β-blockers could worsen hypotension and bronchospasm. Corticosteroids might help with refractory shock but are not specific. Calcium and methylene blue have no role in carcinoid crisis management. The apical sparing pattern reflects catecholamine-mediated stunning rather than primary cardiac ischemia.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: Known metastatic carcinoid syndrome; emergent surgery (high-risk trigger); intraoperative profound hypotension refractory to fluids and phenylephrine; TEE showing global hypokinesis with apical sparing (stress/takotsubo-like stunning); need for a “specific pharmacologic intervention.” This constellation is classic for carcinoid crisis with massive mediator (notably serotonin) release. The standard specific therapy is IV octreotide bolus/infusion to block further mediator release.\\n\\nChoice A (IV octreotide) directly targets the pathophysiology and is guideline-consistent as first-line treatment of carcinoid crisis. B (corticosteroids) are nonspecific adjuncts and not primary/specific therapy. C (β-blocker) risks worsening hypotension and bronchospasm during a vasodilatory shock state. D (calcium gluconate) has no established role here. E (methylene blue) is used for vasoplegic shock from NO pathways, not carcinoid mediator release; carcinoid crises may present with either hypo- or hypertension, but octreotide remains the specific treatment.\\n\\nMain medical accuracy issue(s): Minor nuance—carcinoid heart disease vs acute catecholamine-mediated stunning terminology—but not misleading. Overall teaching is accurate.\\n\\nMinimal fix: Clarify in explanation that the acute LV dysfunction is stress-mediated during carcinoid crisis, and reserve “carcinoid heart disease” term for chronic valvular lesions, to improve precision.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: Known metastatic carcinoid syndrome; emergent surgery (high-risk trigger); intraoperative profound hypotension refractory to fluids and phenylephrine; TEE showing global hypokinesis with apical sparing (stress/takotsubo-like stunning); need for a “specific pharmacologic intervention.” This constellation is classic for carcinoid crisis with massive mediator (notably serotonin) release. The standard specific therapy is IV octreotide bolus/infusion to block further mediator release.\n\nChoice A (IV octreotide) directly targets the pathophysiology and is guideline-consistent as first-line treatment of carcinoid crisis. B (corticosteroids) are nonspecific adjuncts and not primary/specific therapy. C (β-blocker) risks worsening hypotension and bronchospasm during a vasodilatory shock state. D (calcium gluconate) has no established role here. E (methylene blue) is used for vasoplegic shock from NO pathways, not carcinoid mediator release; carcinoid crises may present with either hypo- or hypertension, but octreotide remains the specific treatment.\n\nMain medical accuracy issue(s): Minor nuance—carcinoid heart disease vs acute catecholamine-mediated stunning terminology—but not misleading. Overall teaching is accurate.\n\nMinimal fix: Clarify in explanation that the acute LV dysfunction is stress-mediated during carcinoid crisis, and reserve “carcinoid heart disease” term for chronic valvular lesions, to improve precision.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-009", "question": "A 28-year-old graduate student presents with 6 months of progressive social withdrawal, odd rituals involving numbers, and vague somatic complaints. He believes his thoughts are being broadcast to others. His speech is tangential with occasional neologisms. Neuropsychological testing shows preserved memory but significant executive dysfunction. MRI brain is normal. Which specific clinical feature most strongly predicts poor response to antipsychotic medication?", "options": ["Poor premorbid social functioning", "Prominent negative symptoms", "Executive dysfunction out of proportion to other deficits", "Later age of onset", "Presence of Schneiderian first-rank symptoms"], "answer": "C", "answer_index": 2, "explanation": "Executive dysfunction that is disproportionately severe compared to other cognitive domains is a hallmark of deficit syndrome schizophrenia, which predicts poor medication response. While negative symptoms and poor premorbid functioning are also poor prognostic factors, the specific pattern of executive dysfunction is the strongest predictor among these options. Later age of onset and first-rank symptoms are generally associated with better prognosis in schizophrenia spectrum disorders.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (likely also M/U contributing)\\nVerdict on keyed answer: Miskeyed\\n\\nKey stem clues: 6 months of social withdrawal, odd rituals, thought broadcasting, tangentiality with neologisms, preserved memory but executive dysfunction, normal MRI. Question explicitly asks: “Which specific clinical feature most strongly predicts poor response to antipsychotic medication?”\\n\\nIn schizophrenia prognostic literature, the most robust classic predictors of poor antipsychotic response/overall prognosis are prominent negative symptoms and poor premorbid social functioning. Executive dysfunction is common and associated with poorer functional outcome, but it is not established as a stronger predictor than negative symptoms or premorbid functioning, nor is “executive dysfunction out of proportion to other deficits” a standard, widely accepted single best predictor of medication nonresponse. The explanation’s linkage to “deficit syndrome” is partially accurate but overstates evidence and is not mainstream board-level teaching.\\n\\nThus B and A are at least as defensible as C, and C is not clearly the best single choice. Among standard exam expectations, B (prominent negative symptoms) is the most accepted answer for poor medication response.\\n\\nMinimal fix: Change the key (and explanation) to B, or rewrite the question to explicitly ask about “deficit schizophrenia characterized by disproportionate executive dysfunction” and support C with clearer, guideline-based references.\\n\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (likely also M/U contributing)\nVerdict on keyed answer: Miskeyed\n\nKey stem clues: 6 months of social withdrawal, odd rituals, thought broadcasting, tangentiality with neologisms, preserved memory but executive dysfunction, normal MRI. Question explicitly asks: “Which specific clinical feature most strongly predicts poor response to antipsychotic medication?”\n\nIn schizophrenia prognostic literature, the most robust classic predictors of poor antipsychotic response/overall prognosis are prominent negative symptoms and poor premorbid social functioning. Executive dysfunction is common and associated with poorer functional outcome, but it is not established as a stronger predictor than negative symptoms or premorbid functioning, nor is “executive dysfunction out of proportion to other deficits” a standard, widely accepted single best predictor of medication nonresponse. The explanation’s linkage to “deficit syndrome” is partially accurate but overstates evidence and is not mainstream board-level teaching.\n\nThus B and A are at least as defensible as C, and C is not clearly the best single choice. Among standard exam expectations, B (prominent negative symptoms) is the most accepted answer for poor medication response.\n\nMinimal fix: Change the key (and explanation) to B, or rewrite the question to explicitly ask about “deficit schizophrenia characterized by disproportionate executive dysfunction” and support C with clearer, guideline-based references.\n", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-010", "question": "A 55-year-old woman with treatment-resistant depression develops progressive cerebellar ataxia, nystagmus, and peripheral neuropathy over 6 months. Brain MRI shows symmetric T2 hyperintensities in the dentate nuclei. She has been on lithium for 15 years with therapeutic levels. Which specific underlying neurodegenerative disorder is suggested by this neurological presentation?", "options": ["Multiple system atrophy-cerebellar type", "Spinocerebellar ataxia type 3", "Cerebrotendinous xanthomatosis", "Gerstmann-Sträussler-Scheinker disease", "Adult-onset Niemann-Pick disease type C"], "answer": "E", "answer_index": 4, "explanation": "Adult-onset Niemann-Pick type C often presents with psychiatric symptoms (including depression or psychosis) years before neurological manifestations. The combination of vertical supranuclear gaze palsy, cerebellar ataxia, and neuropsychiatric features is characteristic. Lithium may unmask or accelerate the presentation. The other options do not typically present with this combination of psychiatric prodrome and specific neurological findings. Cerebrotendinous xanthomatosis causes tendon xanthomas and diarrhea, not typically psychiatric symptoms.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: U/M. Verdict on keyed answer: Not uniquely determinable. The stem describes a 55-year-old with long-standing treatment-resistant depression who develops progressive cerebellar ataxia, nystagmus, peripheral neuropathy, and symmetric T2 hyperintensities in the dentate nuclei. The question asks for a specific underlying neurodegenerative disorder. Adult-onset Niemann-Pick type C can present with psychiatric symptoms and ataxia, but key hallmark findings (vertical supranuclear gaze palsy, cognitive decline, hepatosplenomegaly) are not mentioned; MRI dentate hyperintensity is not classic for NPC and is not documented as a defining feature. Other options (MSA-C, SCA3, GSS, cerebrotendinous xanthomatosis) also involve adult-onset ataxia and neuropsychiatric features; the stem does not provide discriminating signs (autonomic failure, parkinsonism, tendon xanthomas, family history, prion features, etc.) to uniquely favor NPC. Thus multiple choices are plausibly defensible or the correct one is indeterminable from given data. The lithium mention is distracting and unsupported by standard evidence. Minimal fix: add a specific hallmark, e.g., “vertical supranuclear gaze palsy and splenomegaly,” or alter options to include a disorder uniquely associated with dentate nucleus T2 hyperintensity.\\n\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U/M. Verdict on keyed answer: Not uniquely determinable. The stem describes a 55-year-old with long-standing treatment-resistant depression who develops progressive cerebellar ataxia, nystagmus, peripheral neuropathy, and symmetric T2 hyperintensities in the dentate nuclei. The question asks for a specific underlying neurodegenerative disorder. Adult-onset Niemann-Pick type C can present with psychiatric symptoms and ataxia, but key hallmark findings (vertical supranuclear gaze palsy, cognitive decline, hepatosplenomegaly) are not mentioned; MRI dentate hyperintensity is not classic for NPC and is not documented as a defining feature. Other options (MSA-C, SCA3, GSS, cerebrotendinous xanthomatosis) also involve adult-onset ataxia and neuropsychiatric features; the stem does not provide discriminating signs (autonomic failure, parkinsonism, tendon xanthomas, family history, prion features, etc.) to uniquely favor NPC. Thus multiple choices are plausibly defensible or the correct one is indeterminable from given data. The lithium mention is distracting and unsupported by standard evidence. Minimal fix: add a specific hallmark, e.g., “vertical supranuclear gaze palsy and splenomegaly,” or alter options to include a disorder uniquely associated with dentate nucleus T2 hyperintensity.\n", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-011", "question": "A 2-month-old infant presents with failure to thrive, vomiting, and hypothermia. Laboratory studies reveal hyponatremia (120 mEq/L), hyperkalemia (6.5 mEq/L), and metabolic acidosis. Newborn screening was normal. Further testing shows elevated 17-hydroxyprogesterone and androstenedione. Genetic analysis reveals a mutation in cytochrome b5. Which specific enzyme deficiency is functionally present in this patient?", "options": ["21-hydroxylase", "11β-hydroxylase", "17α-hydroxylase", "3β-hydroxysteroid dehydrogenase", "P450 oxidoreductase"], "answer": "E", "answer_index": 4, "explanation": "Cytochrome b5 mutations impair electron transfer to P450c17 (17,20-lyase activity), creating a combined 17α-hydroxylase/17,20-lyase deficiency pattern. This explains the elevation of 17-hydroxyprogesterone (due to impaired 17,20-lyase) alongside mineralocorticoid deficiency. The clinical picture resembles 21-hydroxylase deficiency but with a distinct steroid profile. Cytochrome b5 is a cofactor required specifically for 17,20-lyase activity of P450c17, not for the hydroxylase function.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: N\\nVerdict on keyed answer: No defensible answer\\nKey stem clues: 2‑month-old with failure to thrive, vomiting, hypothermia; labs with severe hyponatremia, hyperkalemia, metabolic acidosis → salt-wasting adrenal crisis; elevated 17-hydroxyprogesterone and androstenedione; mutation in cytochrome b5; question asks: “Which specific enzyme deficiency is functionally present?”\\nMain logical issues: The stem clearly identifies a cytochrome b5 mutation; the explanation correctly notes that cytochrome b5 is a cofactor modulating 17,20-lyase activity of P450c17, not an enzyme in the answer list. The keyed answer, P450 oxidoreductase (E), is a different electron donor for multiple P450s, not “functionally” identical to loss of cytochrome b5; they are distinct proteins with different phenotypes. None of the listed classic steroidogenic enzyme deficiencies (A–D) captures the cofactor defect described; E is also incorrect mechanistically. Thus no option is medically defensible as the best representation of a cytochrome b5 defect.\\nMain medical accuracy issues: Misidentification of cytochrome b5 defect as P450 oxidoreductase deficiency.\\nMinimal fix: Change the question to ask “Which cofactor defect is present?” and include “Cytochrome b5” as an option, or change the mutation in the stem to P450 oxidoreductase if choice E is to be correct.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: N\nVerdict on keyed answer: No defensible answer\nKey stem clues: 2‑month-old with failure to thrive, vomiting, hypothermia; labs with severe hyponatremia, hyperkalemia, metabolic acidosis → salt-wasting adrenal crisis; elevated 17-hydroxyprogesterone and androstenedione; mutation in cytochrome b5; question asks: “Which specific enzyme deficiency is functionally present?”\nMain logical issues: The stem clearly identifies a cytochrome b5 mutation; the explanation correctly notes that cytochrome b5 is a cofactor modulating 17,20-lyase activity of P450c17, not an enzyme in the answer list. The keyed answer, P450 oxidoreductase (E), is a different electron donor for multiple P450s, not “functionally” identical to loss of cytochrome b5; they are distinct proteins with different phenotypes. None of the listed classic steroidogenic enzyme deficiencies (A–D) captures the cofactor defect described; E is also incorrect mechanistically. Thus no option is medically defensible as the best representation of a cytochrome b5 defect.\nMain medical accuracy issues: Misidentification of cytochrome b5 defect as P450 oxidoreductase deficiency.\nMinimal fix: Change the question to ask “Which cofactor defect is present?” and include “Cytochrome b5” as an option, or change the mutation in the stem to P450 oxidoreductase if choice E is to be correct.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-012", "question": "A 6-year-old boy with cystic fibrosis presents with recurrent epistaxis and digital clubbing. Chest CT shows extensive bronchiectasis with mosaic perfusion. Echocardiogram demonstrates right ventricular enlargement with an estimated pulmonary artery systolic pressure of 65 mmHg. Which specific genetic variant, when co-inherited with CFTR mutations, is most strongly associated with the development of severe pulmonary hypertension in cystic fibrosis?", "options": ["BMPR2 mutation", "ACE I/D polymorphism", "TGF-β1 codon 10 polymorphism", "Alpha-1 antitrypsin ZZ genotype", "ABCC8 mutation"], "answer": "A", "answer_index": 0, "explanation": "Co-inheritance of BMPR2 mutations, even in heterozygous state, dramatically accelerates pulmonary hypertension development in cystic fibrosis patients. While chronic hypoxia from lung disease contributes to PH, BMPR2 mutations predispose to severe vasculopathy out of proportion to lung disease severity. The other genetic variants may modify CF phenotype but do not specifically drive pulmonary hypertension development. BMPR2 mutations are the most well-established genetic risk factor for heritable pulmonary arterial hypertension.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: U/K (underspecified and likely miskeyed)\\nVerdict on keyed answer: Not uniquely determinable; BMPR2 is a reasonable guess but not clearly supported as “co-inherited modifier” specific to CF.\\n\\nKey stem clues: 6-year-old with cystic fibrosis, severe bronchiectasis, marked pulmonary hypertension (RV enlargement, PASP 65 mmHg). Question explicitly asks for “specific genetic variant, when co-inherited with CFTR mutations, most strongly associated with development of severe pulmonary hypertension in CF.” Options are general cardiopulmonary modifier genes (BMPR2, ACE I/D, TGF-β1 codon 10, A1AT ZZ, ABCC8).\\n\\nMain logical issues: The literature describes BMPR2 as the principal heritable PAH gene, but a specific, well‑established association of *co-inherited BMPR2 variants in CF patients* driving severe PH is not standard, widely accepted knowledge at board level. None of the listed variants are clearly established CF-specific PH modifiers; several (e.g., BMPR2, A1AT ZZ) plausibly worsen lung/vascular disease. This makes the question rest on a niche, poorly established claim, so a unique best answer cannot be confidently derived from standard knowledge.\\n\\nMain medical accuracy issues: The explanation overstates the evidence that BMPR2 co-inheritance “dramatically accelerates” PH in CF.\\n\\nMinimal fix: Reframe stem to a general PAH question (remove CF modifier context) or cite BMPR2 as heritable PAH gene without CF-specific claim, or supply a reference-based teaching note for CF–BMPR2 data.\\n\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U/K (underspecified and likely miskeyed)\nVerdict on keyed answer: Not uniquely determinable; BMPR2 is a reasonable guess but not clearly supported as “co-inherited modifier” specific to CF.\n\nKey stem clues: 6-year-old with cystic fibrosis, severe bronchiectasis, marked pulmonary hypertension (RV enlargement, PASP 65 mmHg). Question explicitly asks for “specific genetic variant, when co-inherited with CFTR mutations, most strongly associated with development of severe pulmonary hypertension in CF.” Options are general cardiopulmonary modifier genes (BMPR2, ACE I/D, TGF-β1 codon 10, A1AT ZZ, ABCC8).\n\nMain logical issues: The literature describes BMPR2 as the principal heritable PAH gene, but a specific, well‑established association of *co-inherited BMPR2 variants in CF patients* driving severe PH is not standard, widely accepted knowledge at board level. None of the listed variants are clearly established CF-specific PH modifiers; several (e.g., BMPR2, A1AT ZZ) plausibly worsen lung/vascular disease. This makes the question rest on a niche, poorly established claim, so a unique best answer cannot be confidently derived from standard knowledge.\n\nMain medical accuracy issues: The explanation overstates the evidence that BMPR2 co-inheritance “dramatically accelerates” PH in CF.\n\nMinimal fix: Reframe stem to a general PAH question (remove CF modifier context) or cite BMPR2 as heritable PAH gene without CF-specific claim, or supply a reference-based teaching note for CF–BMPR2 data.\n", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-013", "question": "A 19-year-old college athlete collapses during basketball practice. Initial rhythm shows pulseless electrical activity. Return of spontaneous circulation occurs after 15 minutes of CPR. ECG shows diffuse ST-segment elevations in precordial leads. Bedside echocardiogram shows severely reduced left ventricular function with apical akinesis. Troponin I is markedly elevated at 50 ng/mL. Coronary angiography is normal. Which specific test result would confirm the most likely diagnosis?", "options": ["Genetic testing for lamin A/C mutation", "Serum catecholamine levels", "Right ventricular endomyocardial biopsy", "Cardiac MRI with gadolinium enhancement", "Plasma metanephrines"], "answer": "D", "answer_index": 3, "explanation": "This describes commotio cordis with subsequent stress-induced (takotsubo) cardiomyopathy. Cardiac MRI would show characteristic apical ballooning with edema on T2-weighted imaging and absence of late gadolinium enhancement, distinguishing it from myocardial infarction. Endomyocardial biopsy is invasive and nonspecific. Genetic testing would be for inherited cardiomyopathies which present differently. Catecholamine levels may be elevated but are not diagnostic. Commotio cordis can trigger neurogenic stunning through direct chest impact.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 19-year-old athlete, sudden collapse during sport, PEA arrest with ROSC, markedly elevated troponin, diffuse ST elevations, severely reduced LV function with apical akinesis, normal coronary angiography. This constellation (apical akinesis/ballooning, normal coronaries, acute presentation under stress) is most consistent with stress-induced (Takotsubo) cardiomyopathy rather than ischemic MI or inherited cardiomyopathy. The question asks which specific test result would *confirm* the most likely diagnosis.\\nCardiac MRI with gadolinium is the best single confirmatory test: it can demonstrate apical ballooning, myocardial edema, and—critically—absence of late gadolinium enhancement, which distinguishes Takotsubo from infarction and myocarditis. Endomyocardial biopsy is invasive and not specific; serum catecholamines may be elevated but are nonspecific; lamin A/C testing applies to familial dilated cardiomyopathy; plasma metanephrines are for pheochromocytoma. The explanation’s mention of commotio cordis is unnecessary but not logically required by the stem and does not affect the answer key. Main medical issue: minor overreach in attributing this to commotio cordis without clear trauma history. Minimal fix: explicitly mention a blunt precordial impact during play or remove “commotio cordis” from the explanation.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 19-year-old athlete, sudden collapse during sport, PEA arrest with ROSC, markedly elevated troponin, diffuse ST elevations, severely reduced LV function with apical akinesis, normal coronary angiography. This constellation (apical akinesis/ballooning, normal coronaries, acute presentation under stress) is most consistent with stress-induced (Takotsubo) cardiomyopathy rather than ischemic MI or inherited cardiomyopathy. The question asks which specific test result would *confirm* the most likely diagnosis.\nCardiac MRI with gadolinium is the best single confirmatory test: it can demonstrate apical ballooning, myocardial edema, and—critically—absence of late gadolinium enhancement, which distinguishes Takotsubo from infarction and myocarditis. Endomyocardial biopsy is invasive and not specific; serum catecholamines may be elevated but are nonspecific; lamin A/C testing applies to familial dilated cardiomyopathy; plasma metanephrines are for pheochromocytoma. The explanation’s mention of commotio cordis is unnecessary but not logically required by the stem and does not affect the answer key. Main medical issue: minor overreach in attributing this to commotio cordis without clear trauma history. Minimal fix: explicitly mention a blunt precordial impact during play or remove “commotio cordis” from the explanation.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-014", "question": "A 57-year-old man presents with 2 days of progressive weakness, dysarthria, and ophthalmoplegia. He recently returned from a fishing trip where he consumed self-caught shellfish. Examination shows descending flaccid paralysis with preserved sensation. Electromyography demonstrates presynaptic neuromuscular blockade. Which specific antagonist administration provides the most definitive diagnostic confirmation?", "options": ["Atropine for muscarinic receptors", "Edrophonium for acetylcholinesterase", "4-aminopyridine for potassium channels", "Guanidine for calcium channels", "Physostigmine for blood-brain barrier penetration"], "answer": "B", "answer_index": 1, "explanation": "This describes botulism from shellfish toxicity. Edrophonium (Tensilon test) may transiently improve weakness in botulism by increasing acetylcholine availability, though the response is less dramatic than in myasthenia gravis. The key is the presynaptic blockade at the neuromuscular junction. Atropine would worsen symptoms by further inhibiting parasympathetic function. 4-aminopyridine helps in Lambert-Eaton syndrome. Guanidine is no longer used. Physostigmine crosses the blood-brain barrier but isn't specific for diagnosis.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: N\\nVerdict on keyed answer: No defensible answer as written\\nKey stem clues: 2 days of descending flaccid paralysis with preserved sensation, cranial nerve involvement (dysarthria, ophthalmoplegia), recent ingestion of self-caught shellfish, EMG showing presynaptic neuromuscular blockade → classic for foodborne botulism. The question asks: “Which specific antagonist administration provides the most definitive diagnostic confirmation?” None of the listed drugs is an accepted diagnostic test for botulism; definitive confirmation is by toxin assay or mouse bioassay, not pharmacologic challenge.\\nLogical issues: The item conflates mechanism/therapy with “definitive diagnostic confirmation.” Edrophonium is a short-acting acetylcholinesterase inhibitor used historically for myasthenia gravis, not for botulism confirmation; any transient effect would be nonspecific and is not standard, so B is not a defensible “most definitive” answer. Other options are likewise non-diagnostic. Thus no option fulfills the stem requirement.\\nMedical accuracy issues: Misstatement that edrophonium use is a recognized diagnostic confirmation test for botulism; incorrect teaching point. Also 4-aminopyridine is more associated with MS symptom treatment than LEMS.\\nMinimal fix: Change the stem to ask for “most appropriate immediate pharmacologic treatment” and key to “equine botulinum antitoxin,” or change options to include toxin assay instead of drugs.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: N\nVerdict on keyed answer: No defensible answer as written\nKey stem clues: 2 days of descending flaccid paralysis with preserved sensation, cranial nerve involvement (dysarthria, ophthalmoplegia), recent ingestion of self-caught shellfish, EMG showing presynaptic neuromuscular blockade → classic for foodborne botulism. The question asks: “Which specific antagonist administration provides the most definitive diagnostic confirmation?” None of the listed drugs is an accepted diagnostic test for botulism; definitive confirmation is by toxin assay or mouse bioassay, not pharmacologic challenge.\nLogical issues: The item conflates mechanism/therapy with “definitive diagnostic confirmation.” Edrophonium is a short-acting acetylcholinesterase inhibitor used historically for myasthenia gravis, not for botulism confirmation; any transient effect would be nonspecific and is not standard, so B is not a defensible “most definitive” answer. Other options are likewise non-diagnostic. Thus no option fulfills the stem requirement.\nMedical accuracy issues: Misstatement that edrophonium use is a recognized diagnostic confirmation test for botulism; incorrect teaching point. Also 4-aminopyridine is more associated with MS symptom treatment than LEMS.\nMinimal fix: Change the stem to ask for “most appropriate immediate pharmacologic treatment” and key to “equine botulinum antitoxin,” or change options to include toxin assay instead of drugs.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-015", "question": "A 34-year-old woman presents with altered mental status following a party where she used 'bath salts.' She is tachycardic, hypertensive, and hyperthermic (40.1°C). Laboratory studies show metabolic acidosis with pH 7.18 and creatinine kinase of 25,000 U/L. Urine drug screen is positive for amphetamines. Despite aggressive cooling and benzodiazepines, she develops rigid-body paralysis with fixed, dilated pupils. Which specific toxin is most likely responsible for this neurological deterioration?", "options": ["Mephedrone-induced serotonin syndrome", "Methylone causing malignant hyperthermia", "MDPV (methylenedioxypyrovalerone) inducing neuroleptic malignant syndrome", "Butylone resulting in sympathomimetic toxidrome", "Alpha-PVP provoking excited delirium"], "answer": "C", "answer_index": 2, "explanation": "MDPV is a potent dopamine-norepinephrine reuptake inhibitor found in bath salts that can cause a syndrome indistinguishable from neuroleptic malignant syndrome, with rigidity, hyperthermia, and autonomic instability. The fixed, dilated pupils and rigid-body paralysis after initial agitation suggest transition to a malignant catatonic state. This differs from serotonin syndrome which features clonus rather than rigidity. Malignant hyperthermia is triggered by inhalational agents, not street drugs. The pattern reflects profound dopaminergic dysregulation.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: N\\nVerdict on keyed answer: No defensible answer\\nKey stem clues: 34-year-old woman, “bath salts” use, severe hyperthermia, metabolic acidosis, massive CK elevation (25,000 U/L), positive amphetamine screen, progression despite benzodiazepines/cooling to rigid-body paralysis and fixed, dilated pupils. Question asks for the *specific toxin* most likely responsible.\\nMain logical issues: The stem describes a severe sympathomimetic / hyperthermic toxidrome with rigidity and rhabdomyolysis that could be seen with multiple synthetic cathinones. However, none of the options accurately correspond to a well-established, distinctive clinical entity: (A) mephedrone is not classically linked to serotonin syndrome per se; (B) malignant hyperthermia is not specifically associated with methylone; (C) MDPV is not known to “induce neuroleptic malignant syndrome” as a defined syndrome—this is extrapolated, nonstandard teaching; (D) and (E) describe general sympathomimetic/excited delirium, which fit early presentation but not clearly the late rigid paralysis with fixed pupils. The keyed rationale relies on an idiosyncratic and non-consensus association, rendering C not clearly best or even well supported vs others.\\nMain medical accuracy issue: Overstated and nonstandard linkage of MDPV with NMS-like state; labeling is misleading.\\nMinimal fix: Reframe options to mechanisms (e.g., “potent dopamine-norepinephrine reuptake inhibitor MDPV”) and remove specific named syndromes, or adjust the stem to describe a known, distinctive toxidrome tied to one specific agent.\\n\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: N\nVerdict on keyed answer: No defensible answer\nKey stem clues: 34-year-old woman, “bath salts” use, severe hyperthermia, metabolic acidosis, massive CK elevation (25,000 U/L), positive amphetamine screen, progression despite benzodiazepines/cooling to rigid-body paralysis and fixed, dilated pupils. Question asks for the *specific toxin* most likely responsible.\nMain logical issues: The stem describes a severe sympathomimetic / hyperthermic toxidrome with rigidity and rhabdomyolysis that could be seen with multiple synthetic cathinones. However, none of the options accurately correspond to a well-established, distinctive clinical entity: (A) mephedrone is not classically linked to serotonin syndrome per se; (B) malignant hyperthermia is not specifically associated with methylone; (C) MDPV is not known to “induce neuroleptic malignant syndrome” as a defined syndrome—this is extrapolated, nonstandard teaching; (D) and (E) describe general sympathomimetic/excited delirium, which fit early presentation but not clearly the late rigid paralysis with fixed pupils. The keyed rationale relies on an idiosyncratic and non-consensus association, rendering C not clearly best or even well supported vs others.\nMain medical accuracy issue: Overstated and nonstandard linkage of MDPV with NMS-like state; labeling is misleading.\nMinimal fix: Reframe options to mechanisms (e.g., “potent dopamine-norepinephrine reuptake inhibitor MDPV”) and remove specific named syndromes, or adjust the stem to describe a known, distinctive toxidrome tied to one specific agent.\n", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-016", "question": "A 29-year-old G3P2 at 34 weeks presents with acute shortness of breath and pleuritic chest pain. CT pulmonary angiography shows multiple segmental pulmonary emboli. She is started on therapeutic enoxaparin. 48 hours later, she develops severe abdominal pain, hypotension, and a rapidly enlarging uterine fundus. Ultrasound shows a large retroplacental hematoma with fetal bradycardia. Emergency cesarean delivery is performed. Pathology examination of the placenta would most likely reveal which specific finding?", "options": ["Extensive perivillous fibrin deposition", "Acute atherosis of spiral arteries", "Massive intervillous thrombosis", "Placental site giant cells with fibrinoid necrosis", "Basal plate myometrial fibers"], "answer": "C", "answer_index": 2, "explanation": "This describes heparin-induced thrombocytopenia (HIT) with thrombosis causing both pulmonary embolism and placental thrombosis/abruption. Massive intervillous thrombosis is characteristic of hypercoagulable states and would explain the acute abruption. HIT typically presents 5-10 days after heparin initiation but can occur rapidly if there has been recent heparin exposure. Acute atherosis is seen in preeclampsia, not thrombotic disorders. Perivillous fibrin deposition is chronic, not acute. The timing suggests HIT rather than underlying thrombophilia.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: U (underspecified, leading toward N)\\nVerdict on keyed answer: Not uniquely determinable\\nKey stem clues: 34-week pregnancy, acute PE, started on therapeutic enoxaparin, only 48 hours later develops retroplacental hematoma and abruption with fetal bradycardia. The explanation asserts HIT with placental thrombosis/abruption and claims massive intervillous thrombosis is characteristic of hypercoagulable states.\\nMain logical issues: The stem never provides platelet counts, prior heparin exposure, or any evidence of HIT or chronic hypercoagulable placental pathology. The abruptio placentae here is more consistent with an acute retroplacental hematoma, not necessarily “massive intervillous thrombosis.” Multiple listed pathologic patterns (e.g., massive intervillous thrombosis, extensive perivillous fibrin deposition) can be associated with hypercoagulable states and recurrent thrombosis; none is clearly specified by the clinical details. The leap from 48-hour enoxaparin exposure to HIT-induced placental pathology is unsupported, and the teaching point relies on unshared assumptions.\\nMain medical accuracy issues: Overstates specificity of massive intervillous thrombosis for hypercoagulable states; timing and type of heparin (LMWH vs UFH) vs HIT are not clarified.\\nMinimal fix: Add explicit lab evidence of HIT (thrombocytopenia, positive PF4 antibodies) and specify that placental pathology shows massive intervillous thrombosis, tying the lesion clearly to the vignette.\\n\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (underspecified, leading toward N)\nVerdict on keyed answer: Not uniquely determinable\nKey stem clues: 34-week pregnancy, acute PE, started on therapeutic enoxaparin, only 48 hours later develops retroplacental hematoma and abruption with fetal bradycardia. The explanation asserts HIT with placental thrombosis/abruption and claims massive intervillous thrombosis is characteristic of hypercoagulable states.\nMain logical issues: The stem never provides platelet counts, prior heparin exposure, or any evidence of HIT or chronic hypercoagulable placental pathology. The abruptio placentae here is more consistent with an acute retroplacental hematoma, not necessarily “massive intervillous thrombosis.” Multiple listed pathologic patterns (e.g., massive intervillous thrombosis, extensive perivillous fibrin deposition) can be associated with hypercoagulable states and recurrent thrombosis; none is clearly specified by the clinical details. The leap from 48-hour enoxaparin exposure to HIT-induced placental pathology is unsupported, and the teaching point relies on unshared assumptions.\nMain medical accuracy issues: Overstates specificity of massive intervillous thrombosis for hypercoagulable states; timing and type of heparin (LMWH vs UFH) vs HIT are not clarified.\nMinimal fix: Add explicit lab evidence of HIT (thrombocytopenia, positive PF4 antibodies) and specify that placental pathology shows massive intervillous thrombosis, tying the lesion clearly to the vignette.\n", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-017", "question": "A 68-year-old man with severe aortic stenosis presents for transcatheter aortic valve replacement under general anesthesia. Shortly after valve deployment, the blood pressure drops from 130/80 to 60/30 mmHg. Transesophageal echocardiography shows new severe mitral regurgitation with a flail posterior leaflet. The left ventricle is hyperdynamic. Which specific maneuver would most likely improve the hemodynamics temporarily?", "options": ["Increase tidal volume to 10 mL/kg", "Administer phenylephrine bolus", "Initiate intra-aortic balloon pump", "Increase inhaled anesthetic concentration", "Admin intravenous fluid bolus"], "answer": "B", "answer_index": 1, "explanation": "In acute severe mitral regurgitation with afterload reduction (from the new valve), increasing afterload with phenylephrine can improve forward flow by reducing the regurgitant fraction. This differs from chronic MR where afterload reduction is beneficial. Fluid administration would worsen pulmonary edema. Increasing anesthetic depth would further depress hemodynamics. An intra-aortic balloon pump is contraindicated in aortic insufficiency, which may occur after TAVR. The hyperdynamic LV suggests adequate preload but excessive afterload mismatch.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Post–TAVR acute hemodynamic collapse; new severe MR with flail posterior leaflet; hyperdynamic LV; goal is a *temporary* maneuver to improve hemodynamics. In acute severe MR, very low afterload plus severe regurgitation can cause hypotension; modest increase in systemic vascular resistance can improve effective forward stroke volume and arterial pressure.\\nOption B (phenylephrine) is most defensible: pure alpha-agonist increases SVR and aortic pressure, supporting coronary perfusion and systemic BP; in this acute setting, small afterload increase may improve hemodynamics despite potentially increasing regurgitant fraction. Other choices:\\nA) Increasing tidal volume raises intrathoracic pressure, decreasing venous return and preload, worsening hypotension.\\nC) IABP may reduce afterload and is not an immediate intra-op “maneuver”; also concern about new AR post-TAVR as noted in rationale.\\nD) Increasing anesthetic concentration lowers SVR and contractility, worsening collapse.\\nE) Fluid bolus risks worsening pulmonary congestion in acute severe MR; LV already hyperdynamic suggesting not preload-limited.\\nMain medical issue: minor controversy—many sources favor afterload reduction in acute MR; however, supporting BP with vasopressors in profound hypotension is accepted. Minimal fix: Clarify that patient is in vasodilatory hypotension after valve deployment and explicitly ask which vasopressor maneuver best stabilizes BP temporarily.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Post–TAVR acute hemodynamic collapse; new severe MR with flail posterior leaflet; hyperdynamic LV; goal is a *temporary* maneuver to improve hemodynamics. In acute severe MR, very low afterload plus severe regurgitation can cause hypotension; modest increase in systemic vascular resistance can improve effective forward stroke volume and arterial pressure.\nOption B (phenylephrine) is most defensible: pure alpha-agonist increases SVR and aortic pressure, supporting coronary perfusion and systemic BP; in this acute setting, small afterload increase may improve hemodynamics despite potentially increasing regurgitant fraction. Other choices:\nA) Increasing tidal volume raises intrathoracic pressure, decreasing venous return and preload, worsening hypotension.\nC) IABP may reduce afterload and is not an immediate intra-op “maneuver”; also concern about new AR post-TAVR as noted in rationale.\nD) Increasing anesthetic concentration lowers SVR and contractility, worsening collapse.\nE) Fluid bolus risks worsening pulmonary congestion in acute severe MR; LV already hyperdynamic suggesting not preload-limited.\nMain medical issue: minor controversy—many sources favor afterload reduction in acute MR; however, supporting BP with vasopressors in profound hypotension is accepted. Minimal fix: Clarify that patient is in vasodilatory hypotension after valve deployment and explicitly ask which vasopressor maneuver best stabilizes BP temporarily.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-018", "question": "A 52-year-old woman with rheumatoid arthritis on adalimumab presents for lumbar fusion surgery. During prone positioning with Jackson table, motor-evoked potentials from the lower extremities are lost. Mean arterial pressure is 65 mmHg. Which specific anesthetic intervention is most likely to restore neuromonitoring signals?", "options": ["Increase sevoflurane concentration to 1.2 MAC", "Administer ketamine 0.5 mg/kg IV", "Increase remifentanil infusion rate", "Administer phenylephrine to MAP 90 mmHg", "Decrease propofol infusion by 50%"], "answer": "D", "answer_index": 3, "explanation": "In prone positioning, spinal cord perfusion is critically dependent on mean arterial pressure due to increased intra-abdominal/venous pressure. For patients with spinal stenosis or compromised blood flow, MAP targets of 85-90 mmHg are often needed to maintain adequate spinal cord perfusion. While propofol and inhalational agents suppress MEPs, the acute loss suggests ischemia rather than anesthetic depth. Ketamine may help but addresses different mechanisms. The key is optimizing perfusion pressure specific to the prone position.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Prone positioning on Jackson table for lumbar fusion; sudden loss of lower-extremity motor-evoked potentials; patient has RA (risk for cervical/spinal pathology); MAP only 65 mmHg; question asks for a *specific anesthetic intervention* to restore neuromonitoring signals. Sudden loss of MEPs with relatively low MAP in a prone spinal case is most concerning for acute spinal cord hypoperfusion rather than gradual anesthetic suppression. Increasing spinal cord perfusion pressure is the most direct, evidence-consistent intervention. Raising MAP to 85–90 mmHg with phenylephrine is standard neurophysiologic monitoring practice. \\nOption analysis: A (increase volatile) would further depress MEPs. B (ketamine) can enhance MEP amplitude but doesn’t address suspected acute ischemia and is slower/less direct. C (more remifentanil) has little benefit to MEPs and can worsen hypotension. D (phenylephrine to MAP 90) directly improves spinal cord perfusion and is guideline-consistent. E (decrease propofol) may modestly improve MEPs but again does not target perfusion and MAP is already low.\\nMinimal fix: Explicitly state that the signal loss is abrupt after positioning and that other technical causes have been excluded.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Prone positioning on Jackson table for lumbar fusion; sudden loss of lower-extremity motor-evoked potentials; patient has RA (risk for cervical/spinal pathology); MAP only 65 mmHg; question asks for a *specific anesthetic intervention* to restore neuromonitoring signals. Sudden loss of MEPs with relatively low MAP in a prone spinal case is most concerning for acute spinal cord hypoperfusion rather than gradual anesthetic suppression. Increasing spinal cord perfusion pressure is the most direct, evidence-consistent intervention. Raising MAP to 85–90 mmHg with phenylephrine is standard neurophysiologic monitoring practice. \nOption analysis: A (increase volatile) would further depress MEPs. B (ketamine) can enhance MEP amplitude but doesn’t address suspected acute ischemia and is slower/less direct. C (more remifentanil) has little benefit to MEPs and can worsen hypotension. D (phenylephrine to MAP 90) directly improves spinal cord perfusion and is guideline-consistent. E (decrease propofol) may modestly improve MEPs but again does not target perfusion and MAP is already low.\nMinimal fix: Explicitly state that the signal loss is abrupt after positioning and that other technical causes have been excluded.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-019", "question": "A 40-year-old man with schizophrenia stable on clozapine develops fever, confusion, and muscle rigidity. Creatinine kinase is elevated at 3,500 U/L. Clozapine is discontinued, and he is treated for neuroleptic malignant syndrome. One week later, he develops profuse diarrhea with abdominal cramping. Stool studies are positive for Clostridium difficile toxin. Which specific immunologic mechanism explains this sequence of events?", "options": ["Clozapine-induced agranulocytosis predisposing to infection", "Anticholinergic effects causing toxic megacolon", "NMS-associated immunoparlysis facilitating C. difficile overgrowth", "Increased intestinal permeability from muscle breakdown", "Clozapine discontinuation causing rebound cholinergic surge"], "answer": "C", "answer_index": 2, "explanation": "NMS induces a systemic inflammatory state followed by immunoparlysis (similar to sepsis), impairing neutrophil function and predisposing to opportunistic infections like C. difficile. This is distinct from clozapine's known agranulocytosis risk. The timing after NMS resolution suggests immunoparlysis rather than direct drug effect. Rebound cholinergic effects from antipsychotic withdrawal are theoretical but not established. The sequence reflects the biphasic immune response in severe systemic inflammatory states.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: N\\nVerdict on keyed answer: No defensible answer\\nKey stem clues: Patient on clozapine; develops classic neuroleptic malignant syndrome (fever, rigidity, markedly elevated CK), clozapine stopped, treated for NMS. One week later, he develops C. difficile colitis (profuse diarrhea, positive toxin). Question asks for the specific immunologic mechanism explaining this sequence.\\nMain logical issues: None of the options provide a medically sound, evidence-based explanation specifically linking NMS to subsequent C. difficile via a defined immunologic mechanism. Choice C (“NMS-associated immunoparlysis”) is not a recognized or standard board-level concept for NMS, and NMS is not classically associated with a biphasic inflammatory/immunoparalysis response like sepsis. Clozapine agranulocytosis (A) is a known risk, but the vignette provides no neutrophil data and C. difficile risk is primarily antibiotic/hospital exposure related. Other choices are speculative or incorrect physiologically.\\nMain medical accuracy issues: The explanation for C is largely extrapolated and not mainstream; presenting it as established teaching is misleading. Mechanistic links to C. difficile are oversimplified/incorrect.\\nMinimal fix: Change the stem to a severe sepsis/ICU scenario with documented immunoparalysis leading to secondary C. difficile, or replace C with an option emphasizing antibiotic-induced disruption of gut flora as the mechanism.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: N\nVerdict on keyed answer: No defensible answer\nKey stem clues: Patient on clozapine; develops classic neuroleptic malignant syndrome (fever, rigidity, markedly elevated CK), clozapine stopped, treated for NMS. One week later, he develops C. difficile colitis (profuse diarrhea, positive toxin). Question asks for the specific immunologic mechanism explaining this sequence.\nMain logical issues: None of the options provide a medically sound, evidence-based explanation specifically linking NMS to subsequent C. difficile via a defined immunologic mechanism. Choice C (“NMS-associated immunoparlysis”) is not a recognized or standard board-level concept for NMS, and NMS is not classically associated with a biphasic inflammatory/immunoparalysis response like sepsis. Clozapine agranulocytosis (A) is a known risk, but the vignette provides no neutrophil data and C. difficile risk is primarily antibiotic/hospital exposure related. Other choices are speculative or incorrect physiologically.\nMain medical accuracy issues: The explanation for C is largely extrapolated and not mainstream; presenting it as established teaching is misleading. Mechanistic links to C. difficile are oversimplified/incorrect.\nMinimal fix: Change the stem to a severe sepsis/ICU scenario with documented immunoparalysis leading to secondary C. difficile, or replace C with an option emphasizing antibiotic-induced disruption of gut flora as the mechanism.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-020", "question": "A 65-year-old woman with treatment-resistant depression receives ketamine infusion therapy. During the infusion, she experiences dissociative symptoms but shows marked mood improvement. However, 48 hours later, she develops severe agitation, paranoid ideation, and visual hallucinations. MRI brain shows new, symmetric T2 hyperintensities in the splenium of the corpus callosum. Which specific pathogenetic mechanism explains this delayed neurological complication?", "options": ["Ketamine-induced excitotoxicity via NMDA receptor internalization", "Unmasking of underlying neurodegenerative disease", "Osmotic demyelination from rapid mood improvement", "Autoimmune encephalitis triggered by glutamatergic activation", "Cerebral hyperperfusion from nitric oxide-mediated vasodilation"], "answer": "A", "answer_index": 0, "explanation": "This describes delayed neurotoxicity from ketamine, possibly via downstream effects of NMDA receptor antagonism including compensatory glutamate surge and excitotoxicity. The splenial lesion is characteristic of transient lesion syndrome associated with various toxins and seizures. This differs from osmotic demyelination which affects pons more commonly. Autoimmune encephalitis would present differently. The timing suggests a metabolic/toxic mechanism rather than unmasking of underlying disease. Ketamine's effects on glutamate homeostasis can cause both therapeutic and adverse neurological effects.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (primary), U (secondary)\\nVerdict on keyed answer: Miskeyed\\nKey stem clues: 65-year-old with ketamine infusion, initial dissociation and mood improvement, followed 48 hours later by agitation, paranoia, visual hallucinations, and new symmetric T2 hyperintensities in the splenium of the corpus callosum (classic reversible splenial lesion / cytotoxic lesion of the corpus callosum). The explanation states a toxic/metabolic excitotoxic mechanism from ketamine, via compensatory glutamate surge.\\nMain logical issue(s): Option A states “excitotoxicity via NMDA receptor internalization.” Excitotoxicity in standard neurobiology is mediated by excessive NMDA receptor activation and intracellular Ca2+ influx, not by receptor internalization (which is usually protective/downregulating). The keyed answer’s mechanism is internally inconsistent with the provided rationale (glutamate surge and excitotoxicity) and accepted pathophysiology. Other options are clearly less plausible, so a toxic/metabolic mechanism is best, but the actual wording of A is mechanistically wrong; thus the question has no fully defensible option and is effectively miskeyed.\\nMain medical accuracy issue(s): Misdescription of excitotoxic mechanism tied to NMDA receptor internalization.\\nMinimal fix: Reword option A to “Ketamine-induced excitotoxicity from compensatory glutamate surge and NMDA overactivation.”\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (primary), U (secondary)\nVerdict on keyed answer: Miskeyed\nKey stem clues: 65-year-old with ketamine infusion, initial dissociation and mood improvement, followed 48 hours later by agitation, paranoia, visual hallucinations, and new symmetric T2 hyperintensities in the splenium of the corpus callosum (classic reversible splenial lesion / cytotoxic lesion of the corpus callosum). The explanation states a toxic/metabolic excitotoxic mechanism from ketamine, via compensatory glutamate surge.\nMain logical issue(s): Option A states “excitotoxicity via NMDA receptor internalization.” Excitotoxicity in standard neurobiology is mediated by excessive NMDA receptor activation and intracellular Ca2+ influx, not by receptor internalization (which is usually protective/downregulating). The keyed answer’s mechanism is internally inconsistent with the provided rationale (glutamate surge and excitotoxicity) and accepted pathophysiology. Other options are clearly less plausible, so a toxic/metabolic mechanism is best, but the actual wording of A is mechanistically wrong; thus the question has no fully defensible option and is effectively miskeyed.\nMain medical accuracy issue(s): Misdescription of excitotoxic mechanism tied to NMDA receptor internalization.\nMinimal fix: Reword option A to “Ketamine-induced excitotoxicity from compensatory glutamate surge and NMDA overactivation.”", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}]